Investors in Health

Sciety was started in 2016 by a founding team with diverse backgrounds in physics, business, medicine and finance. Since our start, we have invested over 1 billion SEK in 25 companies, whereof 8 companies have been successfully acquired or listed on the stock exchange. We are based in Stockholm, but travel across the Nordics to meet with leading ventures and investors.

Segulah Medical Acceleration specializes in investing in and nurturing transformative businesses focused on medical technologies and associated value chain solutions. These companies leverage cutting-edge research to develop real-world applications in areas like medical devices, diagnostics, and life science tools. Segulah Medical Acceleration plays a pivotal role in bridging the gap between innovative concepts and commercial validation, facilitating the global market entry of advanced medical research solutions.

Karolinska Development AB is an investment firm focused on identifying and nurturing medical innovations. It invests in companies that develop these innovations into products aimed at improving patient outcomes and achieving robust financial returns. The company leverages access to cutting-edge medical research from institutions like the Karolinska Institutet, aiming to build successful ventures around leading scientists. Karolinska Development manages a portfolio of 10 companies focused on innovative treatments for severe diseases. Its leadership includes venture capital experts, experienced entrepreneurs, and a global network of specialists.

Curus is a rapidly expanding investment firm specializing in digital health across the Nordic region, investing across early-stage to growth phases. With a portfolio spanning from minority stakes to fully owned subsidiaries, Curus has made approximately 22 investments to date, supporting prominent entrepreneurs like those behind Mindler, Doctrin, Knodd, Findout Diagnostic, Health Integrator, and Medicheck. Founded as the investment arm of Add Health Media, Curus aims to empower top-tier founders with capital, expertise, strategic guidance, and network access to foster long-term business growth. Supported by seasoned experts in digital health, Curus actively seeks new investment opportunities and acquisitions that complement its subsidiary, Add Health Media. The firm is backed by long-term investors including Alfvén & Didrikson, Stefan Bengtsson's CBS Capital, Alex Stendahl's Stone Valley Group, Lars Lindgren's Venture Securities, Christian Dahlberg (former CEO of SEB in New York), and Johan Bloom, founder of Curus and Add Health Media.

VEQ, headquartered in Stockholm, is an investment company dedicated to supporting early-stage technology founders striving for positive impact. Specializing in pre-seed and seed stages across Europe, with a particular focus on the Nordics and the Baltics, VEQ acts as a long-term and engaged owner. The firm's mission is to assist founders in transforming innovative ideas into successful and profitable businesses through strategic investment and active support.

CBC Investment Group invests in early stage IT and MedTech companies with a high level of innovation and a globally scalable business model. CBC also maintains a network of non-professional private investors that are given the opportunity to invest in companies within the CBC portfolio.

Alfvén & Didrikson is an active and long-term backer of passionate entrepreneurs and ambitious teams. Since 2010, the Alfvén & Didrikson team has made investments in fast growing European companies such as Trustly, Quinyx, Acast, Mentimeter, Tellent and Airmee.

Flerie is a proactive, long-term investor in the life sciences sector, specializing in biotech and pharmaceutical investments on a global scale. Headquartered in Stockholm and London, Flerie oversees a diverse portfolio of more than 30 investments spanning across Europe, Israel, and the US. Their mission is to empower innovative organizations primarily in drug development and related services, offering essential resources and expertise to foster success. Flerie manages assets totaling over SEK 3,000 million across three distinct segments: Product Development, Commercial Growth, and Limited Partnerships.

LU Innovation offers diverse funding opportunities tailored to support research-based innovation projects. They provide grants such as Verification for Collaboration (VFS) and Verification for Growth (VFT), aimed at fostering collaborations and validating business concepts. Additionally, they offer accelerator investments to expedite market entry for promising ventures. Students can benefit from test support grants and Leapfrogs scholarships to explore and develop business ideas. LU Innovation also facilitates equity capital investments through LU Holding, focusing on scalable ventures with strong growth potential and capable teams. Their initiatives aim to nurture innovation and facilitate impactful collaborations between academia, public organizations, non-profits, and businesses.

Re:food is a transatlantic growth equity firm that partners with companies advancing sustainability across the agri-food industry in North America and Europe.

Wellstreet Ventures' Ventures II Fund continues their successful approach from their first fund, targeting early-stage startups in D2C, B2B, SaaS, and product sectors. They prioritize diverse founders with strong commercial acumen and a growth mindset. Key investment criteria include enhancing customer experience, utilizing data-driven models, and adhering to proactive ESG standards. They focus on startups poised for mainstream adoption, ensuring strategic early-stage investments.

Spintop Ventures is an early-stage venture capital firm specializing in technology investments, particularly in software-based companies from the Nordics. Since 2010, they have successfully invested in companies like Small Giant Games, MariaDB Corporation, and Crosser Technologies, several of which have been acquired by major global technology leaders. Their focus is on fostering these companies to become industry leaders and promoting long-term sustainability in society.